Garland Jonathan Todd - Insider Non-Derivative Transactions at Cytek Biosciences, Inc. (CTKB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 18, 2023, Garland Jonathan Todd's relationship to Cytek Biosciences, Inc. (CTKB) is Officer (Chief Commercial Officer), and currently has 9,839 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTKB insiders.
Data Source: SEC.
Garland Jonathan Todd - Insider Non-Derivative Transactions of CTKB Common Stock
Garland Jonathan Todd - Insider Non-Derivative Transactions at CTKB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 19, 2023 | F -- (Common Stock) | 760 | 8.46 | 7078 |
| Aug 19, 2023 | M -- (Common Stock) | 1951 | 0 | 7838 |
| Aug 19, 2023 | F -- (Common Stock) | 1076 | 8.46 | 8763 |
| Aug 19, 2023 | M -- (Common Stock) | 2761 | 0 | 9839 |
| May 19, 2023 | F -- (Common Stock) | 3040 | 6.69 | 4764 |
| May 19, 2023 | F -- (Common Stock) | 717 | 6.69 | 5887 |
| May 19, 2023 | M -- (Common Stock) | 1840 | 0 | 6604 |
| May 19, 2023 | M -- (Common Stock) | 7804 | 0 | 7804 |